An Open-label Clinical Trial to Compare the Safety and Effectiveness of Adaptive Versus Conventional Deep Brain Stimulation

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2022

Primary Completion Date

August 30, 2024

Study Completion Date

December 31, 2026

Conditions
Parkinson Disease
Interventions
DEVICE

adaptive DBS delivered through AlphaDBS IPG System

"The AlphaDBS IPG System delivers both conventional DBS and adaptive DBS. Adaptive DBS is a programming mode that provides stimulation in a closed-loop adaptive real-time fashion, using a biosignal recorded from the same macro-electrodes routinely implanted for DBS as an input variable."

DEVICE

conventional DBS delivered through AlphaDBS IPG System

The AlphaDBS IPG System delivers both conventional DBS and adaptive DBS. Conventional DBS is programmed by DBS specialists.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Newronika

INDUSTRY

NCT05262348 - An Open-label Clinical Trial to Compare the Safety and Effectiveness of Adaptive Versus Conventional Deep Brain Stimulation | Biotech Hunter | Biotech Hunter